Oct 9, 2015

Nestlé Health Science to invest CHF 67 million in US Product Technology Centre

Nestlé Health Science, a Nestlé subsidiary dedicated to developing nutritional solutions for people with specific medical conditions, is investing CHF 67 million (USD 70 million) in a new Product Technology Centre in Bridgewater, New Jersey.

As part of Nestlé’s global R&D network, the facility will focus on developing innovative nutritional therapies that improve nutritional status and health outcomes for people in the US and other parts of the world.

Read the press release on the Nestlé Health Science website